These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16322856)

  • 21. Latanoprost is effective in reducing high intraocular pressure associated with Graves' ophthalmopathy.
    Gumińska M; Kłysik A; Siejka A; Jurowski P
    Klin Oczna; 2014; 116(2):89-93. PubMed ID: 25345284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tear meniscus measurement in the diagnosis of dry eye.
    Mainstone JC; Bruce AS; Golding TR
    Curr Eye Res; 1996 Jun; 15(6):653-61. PubMed ID: 8670769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential of tear proteomics for diagnosis and management of orbital inflammatory disorders including Graves' ophthalmopathy.
    Khazaei H; Khazaei D; Verma R; Ng J; Wilmarth PA; David LL; Rosenbaum JT
    Exp Eye Res; 2021 Dec; 213():108813. PubMed ID: 34742692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptoms and signs of dry eye in children with Graves' ophthalmopathy.
    Jankauskiene J; Jarusaitiene D
    Saudi J Ophthalmol; 2023; 37(2):149-153. PubMed ID: 37492217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigations of ocular changes, extraocular muscle thickness, and eye movements in Graves' ophthalmopathy.
    Jankauskiene J; Imbrasiene D
    Medicina (Kaunas); 2006; 42(11):900-3. PubMed ID: 17172791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short Tear Film Breakup Time-Type Dry Eye.
    Tsubota K
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES64-DES70. PubMed ID: 30481808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staged operation for Graves' ophthalmopathy.
    Liao CL; Kao SC; Chang TC; Hou PK
    J Formos Med Assoc; 1996 Sep; 95(9):680-5. PubMed ID: 8918056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subjective and Objective Evaluation of the Effect of Blink Type on Tear-film Breakup Time and Its Estimation.
    Szczesna-Iskander DH; Llorens Quintana C
    Optom Vis Sci; 2020 Nov; 97(11):954-961. PubMed ID: 33122497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare concurrent ocular myasthenia gravis and Graves' ophthalmopathy in a man with Poland syndrome: a case report.
    Tang J; Qin C
    BMC Neurol; 2020 Dec; 20(1):444. PubMed ID: 33297974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability of a new modified tear breakup time method: dry tear breakup time.
    Kim KT; Kim JH; Kong YT; Chae JB; Hyung S
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1355-61. PubMed ID: 26092632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
    Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
    Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An investigation of vital staining of the ocular surface and BUT of the tear film in Chinese].
    Zhang HC
    Zhonghua Yan Ke Za Zhi; 1990 Jan; 26(1):43-6. PubMed ID: 1695563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of tear proteins in Graves' ophthalmopathy by high performance liquid chromatography.
    Khalil HA; de Keizer RJ; Kijlstra A
    Am J Ophthalmol; 1988 Aug; 106(2):186-90. PubMed ID: 3400761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of tear films tests in type 2 diabetes.
    Rahman A; Yahya K; Ahmed T; Sharif-Ul-Hasan K
    J Pak Med Assoc; 2007 Dec; 57(12):577-81. PubMed ID: 18173037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies.
    Eckstein AK; Finkenrath A; Heiligenhaus A; Renzing-Köhler K; Esser J; Krüger C; Quadbeck B; Steuhl KP; Gieseler RK
    Acta Ophthalmol Scand; 2004 Jun; 82(3 Pt 1):291-7. PubMed ID: 15115450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with sjögren syndrome.
    Ibrahim OM; Dogru M; Kawashima S; Wakamatsu TH; Tsubota K; Fujishima H
    Cornea; 2013 May; 32(5):653-7. PubMed ID: 23146930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye.
    Yokoi N; Takehisa Y; Kinoshita S
    Am J Ophthalmol; 1996 Dec; 122(6):818-24. PubMed ID: 8956636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dry Eye Syndrome in Non-Exophthalmic Graves' Disease.
    Bruscolini A; Abbouda A; Locuratolo N; Restivo L; Trimboli P; Romanelli F
    Semin Ophthalmol; 2015; 30(5-6):372-6. PubMed ID: 24460515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Graves Disease on Ocular Surface and Corneal Epithelial Thickness in Patients With and Without Graves Orbitopathy.
    Carreira AR; Rodrigues-Barros S; Moraes F; Loureiro T; Machado I; Campos P; Nobre Cardoso J; Campos N
    Cornea; 2022 Apr; 41(4):443-449. PubMed ID: 34029245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extraocular muscle repositioning as the last therapeutic option for a patient with a severe course of Graves' Ophthalmopathy: a case report.
    Rau A; Klopfer M; Rommel N; Rau-Fornefeld M; Kolk A
    BMC Ophthalmol; 2018 Feb; 18(1):56. PubMed ID: 29482520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.